## MOA
- 阻斷生物胺的主要生理失活途徑來增強其作用
- 失活途徑
	- MAO A/B degradation 
	- reuptake by transport into nerve terminals
- [[Transporters]] 
	- NE transporter (NET)
	- 5-HT transporter (SERT)
	- dopamine transporter (DAT)
## Antidepressants
### TCAs 及相關藥 (Tricyclic antidepressant)
- Amitriptyline (Ttyptanol)
- Imipramine (Tofrani)
### SSRIs (Selective serotonin reuptake inhibitor)
- Fluoxetine (Prozac)
- Trazodone (Mesyrel)
### RIMA (Reversible inhibitor of MAO A)
- Moclobemide (Aurorix)
### SDRI (Selective dopamine reuptake inhibitor)
- Bupropion (Wellbutrin)
### NaSSA (α<sub>2</sub> antagonist；noradrenergic-specifie serotoninergic) 
- Mirtazapine (Remeron)
## Special issue: Postpartum depression (PPD)
- 治療首選 Zulresso® (brexanolone)
	- 異位正向調節 GABAa receptor $\rightarrow$  增加GABA的抑制效應
	- IV
## DDI
- MAOIs + TCAs
	- hypersympathetic response
- MAOIs + L-dopa
	- acute hypertensive reaction
- MAOIs + SSRI
	- 致命
- [[Barbiturates (Thiopental and Methohexital)|Barbiturates]] 
	- 誘導 [[Cytochrome P-450 Enzymes]] 
- serotonin syndrome
	- hyperthermia, shivering (寒戰), myoclonus (肌陣縮症), agitation (精神激昂), hypomania, nausea, tremor and coma